Cutler Group LP Biogen Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $3.25 Million - $3.75 Million	-11,800 Reduced 96.72%	400 $10,000
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $12.4 Million - $14.1 Million	-48,300 Reduced 79.83%	12,200 $8,000
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $201,952 - $245,376	800 Added 1.34%	60,500 $415,000
Q3 2022 Oct 25, 2022	BUY	$194.69 - $268.46 $5.47 Million - $7.54 Million	28,100 Added 88.92%	59,700 $432,000
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $2.55 Million - $3.03 Million	13,600 Added 75.56%	31,600 $676,000
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $3.89 Million - $4.91 Million	-20,100 Reduced 52.76%	18,000 $594,000
Q4 2021 Jan 18, 2022	BUY	$223.92 - $287.77 $7.48 Million - $9.61 Million	33,400 Added 710.64%	38,100 $270,000
Q2 2021 Jul 19, 2021	SELL	$259.0 - $414.71 $1.81 Million - $2.9 Million	-7,000 Reduced 59.83%	4,700 $100,000
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $413,015 - $483,871	1,700 Added 17.0%	11,700 $76,000
Q4 2020 Jan 21, 2021	BUY	$236.26 - $355.63 $2.24 Million - $3.38 Million	9,500 Added 1900.0%	10,000 $74,000
Q3 2020 Oct 27, 2020	SELL	$264.77 - $305.71 $794,310 - $917,129	-3,000 Reduced 85.71%	500 $7,000
Q2 2020 Jul 22, 2020	SELL	$258.66 - $342.55 $258,660 - $342,550	-1,000 Reduced 22.22%	3,500 $87,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $2.2 Million - $2.8 Million	-8,200 Reduced 64.57%	4,500 $83,000
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $2.33 Million - $3.22 Million	10,600 Added 504.76%	12,700 $85,000
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $761,040 - $853,580	-3,500 Reduced 62.5%	2,100 $46,000
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $877,160 - $966,880	-4,000 Reduced 41.67%	5,600 $20,000
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $4.55 Million - $7.12 Million	-21,000 Reduced 68.63%	9,600 $297,000
Q4 2018 Feb 05, 2019	BUY	$278.5 - $352.75 $584,850 - $740,775	2,100 Added 7.37%	30,600 $183,000
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $528,318 - $690,894	-1,800 Reduced 5.94%	28,500 $42,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $103,008 - $122,764	-400 Reduced 1.3%	30,300 $377,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $4.34 Million - $6.14 Million	-16,700 Reduced 35.23%	30,700 $686,000
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $16.9 Million - $18.9 Million	-54,900 Reduced 53.67%	47,400 $540,000
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $28.8 Million - $33.7 Million	102,300	102,300 $583,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.13 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.08 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.74 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.34 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.07 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account